Drug did not fail was not futile and did not have safety issues. The Grade 4 could not separate since all patients got better - sure not perfect but a lot better than if all got worse or didn't get better. There was separation in the Grade 3 and we need un-blinding for more info.
Insiders cannot buy now they are in a blackout until 10Q as is the norm. I think its very likely multiple board members will be buying on open market as soon as they can because I am told everyone in the company thinks the selloff is overdone . Also company continues to work on value drivers they have disclosed publicly including talks with med device companies as recently disclosed (guidance remains same) have been going on for months and sales and installations are coming as is TCAI EP live.
My personal opinion is PURE EP is worth a lot more than the current market cap and will be worth multiples of it in 6 months and that if MMPD proceeds to Phase 3 the company will find a way to monetize the drug and a portion or all of the 69% they own of VCLR. I also do believe the company will clarify some things as you ask since everyone I know who has talked to them said that should be a priority.